The Press Room

KSP Specialty Pharmacy is pleased to announce that it has achieved accreditation through the Accreditation Commission for Health Care (ACHC) for its pharmacy services. Accreditation is a process through which health care organizations demonstrate compliance with national standards. Accreditation by ACHC reflects an organization’s dedication and commitment to meeting standards that facilitate a higher level of performance and patient care. ACHC is a nonprofit organization that has stood as a symbol of qu...

The New England Journal of Medicine Congratulations to Jeffrey Zonder, M.D., leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team at Karmanos Cancer Institute. Dr. Zonder co-authored a paper that was recently published by The New England Journal of Medicine. Titled “Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis,” the paper includes the results of a randomized trial, which led to the first FDA approval of any therapy for AL amyloidosis: Daratumumab-FasPro + CyBor...

The Flint Courier News Hayley Thompson, Ph.D., associate center director of Community Outreach & Education at the Barbara Ann Karmanos Cancer Institute will be a co-investigator on a study examining colorectal cancer screening and health equity. The primary goal is to build on a program of research centered around improving take-home colorectal cancer screening among African Americans as a route to achieving greater screening equity. The study is funded by a $1.7 million Research Scholar Grant from ...

Black Health Matters.com Jennifer Beebe-Dimmer, program leader of the Population Studies and Disparities Research Program at Karmanos Cancer Institute and Wayne State University School of Medicine shares findings from her recent study, which shows that most black cancer survivors do not get the recommended amount of activity. This study included 1,500 black survivors of the four most common cancers (lung, breast, prostate and colon) who completed a survey with a follow-up a year later. Of those, 60 perc...

Health Central Howard Katz, a Karmanos patient from Bloomfield Township, MI tells his story in an article about National Cancer Institute (NCI) – designated cancer centers and the importance of a multidisciplinary approach in cancer care. Click here to read the article.

MedCity News Elisabeth Heath, M.D., FACP, leader of the Genitourinary Multidisciplinary Team at Karmanos Cancer Institute, discussed ways to drive diverse participation in precision medicine at the MedCity INVEST Precision Medicine virtual conference. She explained that actively encouraging minority patients to sign up for clinical trials and research studies is key. Read the full article here . To watch a recording of the virtual conference session, click here .

The Barbara Ann Karmanos Cancer Institute is pleased to announce the appointment of two board of director members: Geaneen Arends, attorney and vice president and director, Butzel Long Sylvester Hester, chairman, Global Automotive Alliance In their roles, Arends and Hester will collaborate with the existing board members to support the Institute’s mission of leading transformative cancer care, research and education. Karmanos treats more than 12,000 new patients annually and is Michigan’s largest cancer...

The Barbara Ann Karmanos Cancer Institute has partnered with more than 70 other National Cancer Institute (NCI)-designated cancer centers and partner organizations to issue a joint statement urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track. Dramatic drops in annual well visits and immunizations during the COVID-19 pandemic have caused a significant vaccination gap and lag in vital preventive services among U.S. children and adolesce...

Health IT Analytics Elisabeth Heath, M.D., FACP, leader of the Genitourinary Multidisciplinary Team at Karmanos Cancer Institute, explains how precision medicine can lead to better outcomes and improved survival rates in cancer care. From the article: "Although precision medicine is a relatively new area, the idea is the same: We want to see what we can identify from the patient's cancer so that we can provide the best care. Sometimes when we talk about stuff like this, people get too hung up on the act...

HealthLeaders Media George Yoo, M.D., FACS Chief Medical Officer and Scott McCarter, Vice President of Information Technology at Karmanos Cancer Institute outline several ways that telehealth can be used in oncology care. From the article: "Telehealth is a great tool, and it is going to stay in the future—it is not just going to be useful during the pandemic. Telehealth is a great way to give initial consults, for example," Dr. Yoo says. Click here to read the complete article.